Alzheimer's Disease and other Dementias Medical Research Another ΓÇ£Alzheimer's in a DishΓÇ¥ Model By Jane Farrell article In October 2014, we posted an article on ThirdAge.com about an ΓÇ£AlzheimerΓÇÖs in a Dish ModelΓÇ¥ (https://thirdage.com/node/2884631) developed at Massachusetts … Read More→
_ Alzheimer's Disease and other Dementias Medical Research A New Cause of Alzheimer's? By Jane Farrell article Blocking a key brainΓÇôcell receptor may eventually lead to neutralizing some consequences of AlzheimerΓÇÖs, according to a new study from … Read More→
Alzheimer's-Related Memory Disorder Identified By Jane Farrell article A multi-institutional study has defined and established criteria for a new neurological disease closely resembling Alzheimer’s disease called primary age-related … Read More→
Alzheimer's Awareness and Support Goes Local in Minnesota By blog As our population ages and no cure or effective treatments for AlzheimerΓÇÖs are in sight, it is apparent we have […]
_ An Update on Alzheimer's Drugs By article EditorΓÇÖs Note: AlzheimerΓÇÖs, a frightening and ultimately fatal disease, is becoming a more crucial issue with every passing year. An … Read More→
_ New Hope for Alzheimer’s Treatment By Sondra Forsyth article A relatively frequent genetic variant turns out to provide significant protection against Alzheimer's disease and can delay the onset of the disease by as much as four years. That is the finding of research done by Judes Poirier, PhD, C.Q., and colleagues at the Douglas Mental Health Institute and McGill University in Montréal. The discovery opens new avenues for treatment against this devastating disease. Dr. presented the study at the annual Alzheimer's Association International Conference in Copenhagen in July 2014.
Antidepressant May Slow Alzheimer's By article Citalopram (brandname Celexa), a commonly prescribed antidepressant, can reduce production of the main ingredient in Alzheimer's brain plaques. That is the finding research done at Washington University School of Medicine in St. Louis and the University of Pennsylvania. The study was published May 14th 2014 in Science Translational Medicine.
Why Do More Women Develop Alzheimer's Disease? By blog Recently, I turned on the radio in my car and heard the last few minutes of an MPR [Minnesota Public Radio] All Things Considered segment about Alzheimer’s disease. A few days later I googled the subject matter and found this MPR link to the audio and an accompanying online story. Take a few minutes to read or listen to the broadcast.
_ Can An Alzheimer's Protein Be Stopped? By Jane Farrell article Researchers have devised a new approach to the treatment of Alzheimer’s by identifying a class of compounds that can decrease a deadly protein associated with dementia. The compounds, called pharmacologic chaperones, can decrease levels of amyloid-beta. That protein is thought to contribute to the development of dementia. The mouse-model study, by researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University, was published in the journal Nature Chemical Biology.
_ The New Challenges of Alzheimer's By Jane Farrell article The growing incidence of Alzheimer’s raises many question beyond diagnosis and, eventually treatment. As a society, we also need to think about the ethical and policy choices we are faced with, an expert says.
I Want To Take The Alzheimer's Test By blog Last night I had trouble getting to sleep. Tossing and turning, I attempted to clear my thoughts, but my brain had other ideas. My mind was on an instant replay loop: A new study reveals researchers have developed a blood test that will predict if a healthy person — someone with no symptoms — is likely to develop Alzheimer’s disease within the next few years. The study focused on people over 70 and was about 90 percent accurate.
_ A Blood Test for Alzheimer's By Jane Farrell article There’s an Alzheimer’s blood test now – a procedure that can detect whether a healthy person will develop mild cognitive impairment or Alzheimer’s within three years. The test has a 90 percent accuracy rate. Described in the April issue of Nature Medicine, the test could lead to the development of treatment for early-stage Alzheimer’s, when therapy would be more effective at slowing or preventing onset of symptoms.
Pen-and-Paper Test to Spot Early Alzheimer's By article The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes to complete, is a reliable tool for evaluating cognitive abilities. Findings by researchers at The Ohio State University Wexner Medical Center confirm the feasibility and efficiency of the tool for community screening of large numbers of people. The study is published in the January 2014 issue of The Journal of Neuropsychiatry and Clinical Neurosciences.
Alzheimer's Disease and other Dementias Medical Research Memory Loss Senior Health Delaying AlzheimerΓÇÖs by 10 Years By article Medical research has yet to discover an Alzheimer’s treatment that effectively slows the disease’s progression, but neuroscientists at the University … Read More→
_ Can I Prevent Dementia? By Jane Farrell article A risk factor is something that may increase the chance of developing a disease. Some risk factors can be controlled … Read More→
_ What Is Mild Cognitive Impairment? By Jane Farrell article Mild cognitive impairment (MCI) is a condition in which people have more memory or thinking problems than other people their … Read More→
_ Memory and Aging By Jane Farrell article Many older adults worry about their memory and other thinking abilities. For example, they might be concerned about taking longer … Read More→
_ Breaking Down AGEs: Insight into How Lifestyle Drives ER-Positive Breast Cancer By Sondra Forsyth article Poor diet and lack of exercise are associated with cancer development, but the underlying biology is not well understood. Advanced … Read More→